In the Matter of Certain Endoscopic Probes for Use in Argon Plasma Coagulation Systems; Notice of Investigation, 28386-28387 [E6-7444]

Download as PDF 28386 Federal Register / Vol. 71, No. 94 / Tuesday, May 16, 2006 / Notices RESPONDENT’S ESTIMATED ANNUAL BURDEN HOURS—Continued Reporting and recordkeeping requirement 204.214(b)(1) and (b)(2) .. § 204.214(b) Is minimum royalty due on a property for which I took relief? (b) If you pay minimum royalty on production from a marginal property during a calendar year for which you are taking cumulative royalty reports and payment relief, and: (1) The annual payment you owe under this subpart is greater than the minimum royalty you paid, you must pay the difference between the minimum royalty you paid and your annual payment due under this subpart; or (2) The annual payment you owe under this subpart is less than the minimum royalty you paid, you are not entitled to a credit because you must pay at least the minimum royalty amount on your lease each year. Total .......................... sroberts on PROD1PC70 with NOTICES Citation 30 CFR 204 ................................................................................... Estimated Annual Reporting and Recordkeeping ‘‘Non-hour’’ Cost Burden: We have identified no ‘‘nonhour’’ cost burdens. Public Disclosure Statement: The PRA (44 U.S.C. 3501 et seq.) provides that an agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Comments: Section 3506(c)(2)(A) of the PRA requires each agency ‘‘* * * to provide notice * * * and otherwise consult with members of the public and affected agencies concerning each proposed collection of information * * *.’’ Agencies must specifically solicit comments to: (a) Evaluate whether the proposed collection of information is necessary for the agency to perform its duties, including whether the information is useful; (b) evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) enhance the quality, usefulness, and clarity of the information to be collected; and (d) minimize the burden on the respondents, including the use of automated collection techniques or other forms of information technology. To comply with the public consultation process, we published a notice in the Federal Register on June 3, 2005 (70 FR 32647), announcing that we would submit this ICR to OMB for approval. The notice provided the required 60-day comment period. We received no comments in response to the notice. If you wish to comment in response to this notice, you may send your comments to the offices listed under the ADDRESSES section of this notice. The VerDate Aug<31>2005 16:06 May 15, 2006 Jkt 208001 Hour burden Frm 00091 Fmt 4703 Sfmt 4703 Annual burden hours Burden covered under OMB Control Number 1010–0140 (expires 10/31/2006). .............................. OMB has up to 60 days to approve or disapprove the information collection but may respond after 30 days. Therefore, to ensure maximum consideration, OMB should receive public comments by June 15, 2006. Public Comment Policy: We will post all comments in response to this notice on our Web site at https:// www.mrm.mms.gov/Laws_R_D/InfoColl/ InfoColCom.htm. We will also make copies of the comments available for public review, including names and addresses of respondents, during regular business hours at our offices in Lakewood, Colorado. Upon request, we will withhold an individual respondent’s home address from the public record, as allowable by law. There also may be circumstances in which we would withhold a respondent’s identity, as allowable by law. If you request that we withhold your name and/or address, state your request prominently at the beginning of your comment. However, we will not consider anonymous comments. We will make all submissions from organizations or businesses, and from individuals identifying themselves as representatives or officials of organizations or businesses, available for public inspection in their entirety. MMS Information Collection Clearance Officer: Arlene Bajusz (202) 208–7744. PO 00000 Average number of annual responses 138 406 Dated: December 28, 2005. Cathy J. Hamilton, Acting Associate Director for Minerals Revenue Management. Editorial Note: This document was received at the Office of the Federal Register on May 11, 2006. [FR Doc. E6–7440 Filed 5–15–06; 8:45 am] BILLING CODE 4310–MR–P INTERNATIONAL TRADE COMMISSION [Inv. No. 337–TA–569] In the Matter of Certain Endoscopic Probes for Use in Argon Plasma Coagulation Systems; Notice of Investigation U.S. International Trade Commission. ACTION: Institution of investigation pursuant to 19 U.S.C. 1337. AGENCY: SUMMARY: Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 10, 2006, under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of ERBE Elektromedizin GmbH of Germany and ERBE USA, Inc. of Marietta, Georgia. A supplement to the complaint was filed on May 2, 2006. The complaint, as supplemented, alleges violations of section 337 in the importation into the United States, the sale for importation, and the sale within the United States after importation of certain endoscopic probes for use in argon plasma coagulation systems by reason of infringement of claims 1, 3, 4, 11, 13, 35, 37, 38, 39, and 41 of U.S. Patent No. E:\FR\FM\16MYN1.SGM 16MYN1 Federal Register / Vol. 71, No. 94 / Tuesday, May 16, 2006 / Notices 5,720,745 and of infringement of U.S. Supplemental Trademark Registration No. 2,637,630. The complaint further alleges that an industry in the United States exists or is in the process of being established, as required by subsection (a)(2) of section 337. The complainant requests that the Commission institute an investigation and, after the investigation, issue a permanent exclusion order and cease and desist orders. ADDRESSES: The complaint, except for any confidential information contained therein, is available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street, SW., Room 112, Washington, DC 20436, telephone 202–205–2000. Hearing impaired individuals are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on 202–205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its Internet server at https:// www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. FOR FURTHER INFORMATION CONTACT: Karin J. Norton, Office of Unfair Import Investigations, U.S. International Trade Commission, telephone 202–205–2606. sroberts on PROD1PC70 with NOTICES Authority: The authority for institution of this investigation is contained in section 337 of the Tariff Act of 1930, as amended, and in section 210.10 of the Commission’s Rules of Practice and Procedure, 19 CFR 210.10 (2005). Scope of Investigation: Having considered the complaint, the U.S. International Trade Commission, on May 10, 2006, ordered that— (1) Pursuant to subsection (b) of section 337 of the Tariff Act of 1930, as amended, an investigation be instituted to determine: (a) Whether there is a violation of subsection (a)(1)(B) of section 337 in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain endoscopic probes for use in argon plasma coagulation systems by reason of infringement of claims 1, 3, 4, 11, 13, 35, 37, 38, 39, or 41 of U.S. Patent No. 5,720,745, and whether an industry in the United States exists or is in the process of being established, as required by subsection (a)(2) of section 337; and VerDate Aug<31>2005 16:06 May 15, 2006 Jkt 208001 (b) Whether there is a violation of subsection (a)(1)(C) of section 337 in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain endoscopic probes for use in argon plasma coagulation systems by reason of infringement of U.S. Supplemental Trademark Registration No. 2,637,630, and whether an industry in the United States exists or is in the process of being established as required by subsection (a)(2) of section 337. (2) For the purpose of the investigation so instituted, the following are hereby named as parties upon which this notice of investigation shall be served: (a) The complainants are— ERBE Elektromedizin GmbH, ¨ ¨ Waldhornlestrabe 17, 72072 Tubingen, Germany ERBE USA, Inc., 2225 Northwest Parkway, Marietta, Georgia 30067. (b) The respondents are the following entities alleged to be in violation of section 337, and are the parties upon which the complaint is to be served: Canady Technology, LLC, 144 Research Drive, Hampton, VA 23666. Canady Technology Germany GmbH, Kanalstrabe 66–74, 12357 Berlin, Germany. KLS Martin GmbH & Co. KG, Am Gansacker 1 B, 79224 Umkirch, Germany. (c) The Commission investigative attorney, party to this investigation, is Karin J. Norton, Esq., Office of Unfair Import Investigations, U.S. International Trade Commission, 500 E Street, SW., Suite 401, Washington, DC 20436. (3) For the investigation so instituted, the Honorable Sidney Harris is designated as the presiding administrative law judge. Responses to the complaint and the notice of investigation must be submitted by the named respondents in accordance with § 210.13 of the Commission’s Rules of Practice and Procedure, 19 CFR 210.13. Pursuant to 19 CFR 201.16(d) and 210.13(a), such responses will be considered by the Commission if received not later than 20 days after the date of service by the Commission of the complaint and the notice of investigation. Extensions of time for submitting responses to the complaint and the notice of investigation will not be granted unless good cause therefor is shown. Failure of a respondent to file a timely response to each allegation in the complaint and in this notice may be deemed to constitute a waiver of the right to appear and contest the allegations of the complaint and this notice, and to authorize the PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 28387 administrative law judge and the Commission, without further notice to the respondents, to find the facts to be as alleged in the complaint and this notice and to enter an initial determination and a final determination containing such findings, and may result in the issuance of a limited exclusion order or cease and desist order or both directed against the respondent. By order of the Commission. Issued: May 11, 2006. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E6–7444 Filed 5–15–06; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Inv. No. 337–TA–570] In the Matter of Certain Flash Memory Chips, Flash Memory Systems, and Products Containing Same; Notice of Investigation U.S. International Trade Commission. ACTION: Institution of investigation pursuant to 19 U.S.C. 1337. AGENCY: SUMMARY: Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 11, 2006, under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of Lexar Media, Inc. of Fremont, California. The complaint alleges violations of section 337 in the importation into the United States, the sale for importation, and the sale within the United States after importation of certain flash memory chips, flash memory systems, and products containing same by reason of infringement of claims 1 and 2 of U.S. Patent No. 6,801,979; claims 1–7 of U.S. Patent No. 6,397,314; and claims 1–13, 15, and 16 of U.S. Patent No. 6,978,342. The complaint further alleges that an industry in the United States exists or is in the process of being established as required by subsection (a)(2) of section 337. The complainant requests that the Commission institute an investigation and, after the investigation, issue a permanent exclusion order and permanent cease and desist orders. ADDRESSES: The complaint, except for any confidential information contained therein, is available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street, SW., Room E:\FR\FM\16MYN1.SGM 16MYN1

Agencies

[Federal Register Volume 71, Number 94 (Tuesday, May 16, 2006)]
[Notices]
[Pages 28386-28387]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7444]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Inv. No. 337-TA-569]


In the Matter of Certain Endoscopic Probes for Use in Argon 
Plasma Coagulation Systems; Notice of Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Institution of investigation pursuant to 19 U.S.C. 1337.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that a complaint was filed with the 
U.S. International Trade Commission on April 10, 2006, under section 
337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of 
ERBE Elektromedizin GmbH of Germany and ERBE USA, Inc. of Marietta, 
Georgia. A supplement to the complaint was filed on May 2, 2006. The 
complaint, as supplemented, alleges violations of section 337 in the 
importation into the United States, the sale for importation, and the 
sale within the United States after importation of certain endoscopic 
probes for use in argon plasma coagulation systems by reason of 
infringement of claims 1, 3, 4, 11, 13, 35, 37, 38, 39, and 41 of U.S. 
Patent No.

[[Page 28387]]

5,720,745 and of infringement of U.S. Supplemental Trademark 
Registration No. 2,637,630. The complaint further alleges that an 
industry in the United States exists or is in the process of being 
established, as required by subsection (a)(2) of section 337.
    The complainant requests that the Commission institute an 
investigation and, after the investigation, issue a permanent exclusion 
order and cease and desist orders.

ADDRESSES: The complaint, except for any confidential information 
contained therein, is available for inspection during official business 
hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street, SW., Room 112, 
Washington, DC 20436, telephone 202-205-2000. Hearing impaired 
individuals are advised that information on this matter can be obtained 
by contacting the Commission's TDD terminal on 202-205-1810. Persons 
with mobility impairments who will need special assistance in gaining 
access to the Commission should contact the Office of the Secretary at 
202-205-2000. General information concerning the Commission may also be 
obtained by accessing its Internet server at https://www.usitc.gov. The 
public record for this investigation may be viewed on the Commission's 
electronic docket (EDIS) at https://edis.usitc.gov.

FOR FURTHER INFORMATION CONTACT: Karin J. Norton, Office of Unfair 
Import Investigations, U.S. International Trade Commission, telephone 
202-205-2606.

    Authority: The authority for institution of this investigation 
is contained in section 337 of the Tariff Act of 1930, as amended, 
and in section 210.10 of the Commission's Rules of Practice and 
Procedure, 19 CFR 210.10 (2005).

    Scope of Investigation: Having considered the complaint, the U.S. 
International Trade Commission, on May 10, 2006, ordered that--
    (1) Pursuant to subsection (b) of section 337 of the Tariff Act of 
1930, as amended, an investigation be instituted to determine:
    (a) Whether there is a violation of subsection (a)(1)(B) of section 
337 in the importation into the United States, the sale for 
importation, or the sale within the United States after importation of 
certain endoscopic probes for use in argon plasma coagulation systems 
by reason of infringement of claims 1, 3, 4, 11, 13, 35, 37, 38, 39, or 
41 of U.S. Patent No. 5,720,745, and whether an industry in the United 
States exists or is in the process of being established, as required by 
subsection (a)(2) of section 337; and
    (b) Whether there is a violation of subsection (a)(1)(C) of section 
337 in the importation into the United States, the sale for 
importation, or the sale within the United States after importation of 
certain endoscopic probes for use in argon plasma coagulation systems 
by reason of infringement of U.S. Supplemental Trademark Registration 
No. 2,637,630, and whether an industry in the United States exists or 
is in the process of being established as required by subsection (a)(2) 
of section 337.
    (2) For the purpose of the investigation so instituted, the 
following are hereby named as parties upon which this notice of 
investigation shall be served:
    (a) The complainants are--
    ERBE Elektromedizin GmbH, Waldh[ouml]rnlestrabe 17, 72072 
T[uuml]bingen, Germany
    ERBE USA, Inc., 2225 Northwest Parkway, Marietta, Georgia 30067.
    (b) The respondents are the following entities alleged to be in 
violation of section 337, and are the parties upon which the complaint 
is to be served:
    Canady Technology, LLC, 144 Research Drive, Hampton, VA 23666.
    Canady Technology Germany GmbH, Kanalstra[beta]e 66-74, 12357 
Berlin, Germany.
    KLS Martin GmbH & Co. KG, Am Gansacker 1 B, 79224 Umkirch, Germany.
    (c) The Commission investigative attorney, party to this 
investigation, is Karin J. Norton, Esq., Office of Unfair Import 
Investigations, U.S. International Trade Commission, 500 E Street, SW., 
Suite 401, Washington, DC 20436.
    (3) For the investigation so instituted, the Honorable Sidney 
Harris is designated as the presiding administrative law judge.
    Responses to the complaint and the notice of investigation must be 
submitted by the named respondents in accordance with Sec.  210.13 of 
the Commission's Rules of Practice and Procedure, 19 CFR 210.13. 
Pursuant to 19 CFR 201.16(d) and 210.13(a), such responses will be 
considered by the Commission if received not later than 20 days after 
the date of service by the Commission of the complaint and the notice 
of investigation. Extensions of time for submitting responses to the 
complaint and the notice of investigation will not be granted unless 
good cause therefor is shown.
    Failure of a respondent to file a timely response to each 
allegation in the complaint and in this notice may be deemed to 
constitute a waiver of the right to appear and contest the allegations 
of the complaint and this notice, and to authorize the administrative 
law judge and the Commission, without further notice to the 
respondents, to find the facts to be as alleged in the complaint and 
this notice and to enter an initial determination and a final 
determination containing such findings, and may result in the issuance 
of a limited exclusion order or cease and desist order or both directed 
against the respondent.

    By order of the Commission.

    Issued: May 11, 2006.
Marilyn R. Abbott,
Secretary to the Commission.
 [FR Doc. E6-7444 Filed 5-15-06; 8:45 am]
BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.